Novo Nordisk
In François Rochon's portfolio · Giverny Capital
Ticker NVO
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Giverny Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Sell | 0 | |
| Q1 2026 | No change | 12,400 | 0.0% |
| Q4 2025 | No change | 12,400 | 0.0% |
| Q3 2025 | No change | 12,400 | 0.0% |
| Q2 2025 | No change | 12,400 | 0.0% |
| Q1 2025 | No change | 12,400 | 0.0% |
| Q4 2024 | No change | 12,400 | 0.0% |
| Q3 2024 | No change | 12,400 | 0.1% |
| Q2 2024 | No change | 12,400 | 0.1% |
| Q1 2024 | No change | 12,400 | 0.1% |
| Q4 2023 | No change | 12,400 | 0.1% |
| Q3 2023 | Add 100% | 12,400 | 0.1% |
| Q2 2023 | No change | 6,200 | 0.1% |
| Q1 2023 | No change | 6,200 | 0.1% |
| Q4 2022 | No change | 6,200 | 0.1% |
| Q3 2022 | No change | 6,200 | 0.0% |
| Q2 2022 | No change | 6,200 | 0.0% |
| Q1 2022 | No change | 6,200 | 0.0% |
| Q4 2021 | Reduce 50% | 6,200 | 0.0% |
| Q3 2021 | Add 100% | 12,400 | 0.0% |
| Q2 2021 | No change | 6,200 | 0.0% |
| Q1 2021 | No change | 6,200 | 0.0% |
| Q4 2020 | No change | 6,200 | 0.0% |
| Q3 2020 | Buy | 6,200 | 0.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.